Bank of America
DALS

Bank of America’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bank of America’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,941
Closed -$242K – 8623
2022
Q1 		$242K Hold
24,941
– – ﹤0.01% 6357
2021
Q4 		$245K Buy
+24,941
New +$244K ﹤0.01% 6385

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of America's DALS Position: Q2 2022 in Review

Bank of America sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q2 2022, closing a stake of 24,941 shares — an estimated $242K sold.

Bank of America first reported a position in DALS in Q4 2021 and held it in 2 quarters. The position peaked at $245K in Q4 2021. 45 funds tracked by Wall St. Rank hold DALS as of Q2 2022.

  • Bank of America reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of America sold 24,941 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $242K.
  • Bank of America first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • Bank of America's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $245K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.